Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive human cancers. Actually, ATC is refractory to conventional therapies, including surgery, chemotherapy, radiotherapy, and radioiodine (131I) therapy. Accordingly, genetic and molecular characterizations of ATC have been frequently and p...
Saved in:
Main Authors: | Rosalba Parenti, Lucia Salvatorelli, Gaetano Magro |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2014/685396 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody
by: Eva Schlein, et al.
Published: (2024-12-01) -
Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood–brain barrier and interacts with amyloid β
by: Rebecca Faresjö, et al.
Published: (2024-12-01) -
Anaplastic Transformation of Papillary Thyroid Cancer in the Retroperitoneum
by: James P. Solomon, et al.
Published: (2015-01-01) -
Endometrioid Adenocarcinoma Metastatic to the Thyroid, Presenting Like Anaplastic Thyroid Cancer
by: Natasha Pollak, et al.
Published: (2011-01-01) -
MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
by: Cesar Seigi Fuziwara, et al.
Published: (2014-01-01)